Dr. Jerry Tan
Dr. Tan received his medical degree from Queen’s University in Kingston, Ontario and trained in internal medicine at the University of Toronto and in dermatology at University of British Columbia and University of Michigan. His general dermatology and aesthetic dermatology practices are in Windsor Ontario Canada. He conducts clinical trials research at Windsor Clinical Research, a clinical trials site in dermatology. Aside from industry grants, he has received research funding from the Canadian Dermatology Foundation and the National Institutes of Health Research.
Research focus includes acne, acne scars and rosacea. Additional interests include outcome measurements and informed shared decision making in dermatology. We have developed 3 patient decision aids in dermatology – acne, psoriasis and hidradenitis suppurativa – available at www.informed-decisions.org
Dr. Tan chairs the working group on clinical practice guidelines of the Canadian Dermatology Association, the rosacea international consensus group (ROSCO) and the acne core outcomes research network (ACORN). He has been an associate editor of the Journal of the American Academy of Dermatology and the British Journal of Dermatology. Over the past 3 decades, Dr. Tan has authored/co-authored more than 100 peer-reviewed publications.
SAT Apr 29
A multicenter evaluation of a ceramide-containing hydrating cream-to-foam cleanser and facial moisturizing lotion for improving acne treatment tolerability and adherence
Objectives:
Evaluate the impact of a ceramide-containing hydrating cream-to-foam cleanser and PM facial moisturizing lotion on acne treatment tolerability and adherence.
Description:
Present and discuss the multicenter, open-label, cohort study of a topical retinoid and daily use of an adjunct cleanser and moisturizer to prevent adverse events and improve compliance with prescription acne treatments.
SAT Apr 29
Unmasking Acne: A closer look at the unmet needs. A clearer view of the road ahead.
After attending this program, attendees will be able to:
- Recognize current unmet needs in acne management
- Explain the limitations of managing acne with currently available treatment options
- Describe the role of androgens in acne pathophysiology, and select appropriate therapies targeting the androgen pathway
Session description:
Despite the acne treatment landscape continually evolving, there still remain significant unmet needs for patients suffering with moderate-to-severe acne. In this session, Dr. Jaggi Rao will discuss these patient needs, along with gaps and challenges of acne management in Canada, while Dr. Leon Kircik will provide insight into the experience of treating acne in the United States, including the use of the newly available topical agent – clascoterone. The presentations will be tied together through a discussion amongst the panelists led by Dr. Jerry Tan, and the session will conclude with an opportunity for the audience to pose questions to the panel.
SUN Apr 30
Vichy Hyperpigmentation Advisory Board
